| Literature DB >> 28315994 |
Abstract
This piece describes the approach by which even a small CADD (Computer-Aided Drug Design) group with limited resources and limited time can achieve substantial success given short budgets and the compressed, urgent environment of a biotech. Some comparisons are made with CADD operations in big pharma.Keywords: Bristol-Myers Squibb; Clinic; Computational chemist; Computer-Aided Drug Design; Lexicon pharmaceuticals
Mesh：
Substances：
Year: 2017 PMID： 28315994 DOI： 10.1007/s10822-017-0018-5
Source DB: PubMed Journal: J Comput Aided Mol Des ISSN： 0920-654X Impact factor: 3.686